Nirvana Announces First Production of Psilocybin and Psilocin
Nirvana Announces First Production of Psilocybin and Psilocin Nirvana Life Sciences (NIRV), a recently listed
Nirvana Announces First Production of Psilocybin and Psilocin Nirvana Life Sciences (NIRV), a recently listed
Magic Mushrooms Have Over 80 Different Species—And Their DNA Is Now Available Online Medicinal Genomics
Help TheraPsil-Supported Patients and Clinicians Fight for Legal Psilocybin By denying Canadians access to psilocybin,
‘I felt more joy than I thought possible’ Steve struggled with depression for 30 years.
Psyence and Filament Health Enter Into Exclusive Licensing Agreements For Natural Psilocybin Products Filament Health
GoDaddy Billionaire Bob Parsons Believes Psychedelics Can Heal Trauma—And He’s Putting His Money (And Brain)
Oklahoma Senators Approve Psilocybin Research Bill But Delete Decriminalization Provision Passed By House The bill,
Magic mushroom compound increases brain connectivity in people with depression “For the first time we
Red Light Holland to Purchase 100 Acres of Farmland in Ontario, Canada as Its Mushroom
Maryland House Gives Initial Approval To Senate-Passed Bill To Fund Psychedelics Research And Access For
Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample A
Nova Mentis to Produce Psilocybin Capsules for Phase 2A Clinical Study Manufacturing Contract with the
New species of psychedelic mushroom believed to live in Kakadu National Park We’d love to
Albert Labs’ Files U.S. Provisional Patent Application for a Cultivation Process for the Production of
Diamond Therapeutics Achieves Last Patient Last Visit in Clinical Trial of Low-Dose Psilocybin TORONTO, March 29,
Cybin Announces Successful Completion of In Vivo Preclinical Studies for its Deuterated Psilocybin Analog CYB003
Nirvana Enters Supply Agreement with Symeres VANCOUVER, BC, March 29, 2022 /CNW/ – Nirvana Life Sciences Inc.,
Creso Pharma’s wholly-owned psychedelics subsidiary, Halucenex Life Sciences Inc. completes important milestones ahead of first
Filament Health Announces Second Patent Issuance The patent describes the extraction and standardization of stable
NeonMind Files New Provisional Patent Application Covering Novel Mechanism of Weight Loss OAKVILLE, ON /
Wesana Health Announces New Findings Indicating Psilocybin Potentiates Impact of an Anti-Depressant CHICAGO and TORONTO,
Red Light Holland Successfully Imports Psilocybin iMicrodose Packs into St. Vincent and the Grenadines Under
Connecticut Lawmakers Approve Bill To Fund Psilocybin And MDMA Therapy A bill that would create
Optimi Health Begins Cultivation of Natural Psilocybin for Use in Clinical Trials VANCOUVER, BC — Optimi
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |